resveratrol has been researched along with Kaposi Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balestrieri, C; Balestrieri, ML; Felice, F; Montoro, P; Oleszek, W; Piacente, S; Pizza, C; Visciano, V | 1 |
1 other study(ies) available for resveratrol and Kaposi Sarcoma
Article | Year |
---|---|
Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis.
Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Bark; Plant Extracts; Platelet Activating Factor; Resveratrol; Sarcoma, Kaposi; Spiro Compounds; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Yucca | 2006 |